Mood and Anxiety Disorders
Charles L. Bowden , M.D., Nancy U. Karren Endowed Chair of Psychiatry, Clinical Professor of Psychiatry and Pharmacology
Jodi Gonzalez Arnold , PhD., Associate Professor
Cervando Martinez , M.D., Professor
Melissa Martinez , M.D., Assistant Professor
Donna J. Roybal , M.D., Assistant Professor, Child & Adolescent Psychiatry
ClinicalPsychiatrists and psychologists of the division provide consultative assessments to mental health professionals in the region, and care for over 200 patients with bipolar disorders, major depression, and anxiety disorders in the Bipolar and Depression Health Care Research Clinic. The clinic provides a strong link to community-provided mental health services, including the Treatment Coordination Center of the Department.
The principal research of the Division is organized around the National Institute of Mental Health (NIMH) funded Center for Improving Bipolar Illness Intervention in Hispanic Communities. The Center, funded since 2004 through 2016, is the only such center to receive support from the NIMH. Center investigators have developed the first comprehensive rating instrument for bipolar disorders. The scale, the Bipolar Inventory of Signs and Symptoms Scale, provides scores on 5 fundamental aspects of bipolar conditions: depression, activation/mania, irritability, anxiety and unrealistic thinking. Center investigators have made major contributions to discovery and application of improved medications and psychotherapeutic techniques for bipolar disorders. The Center also has addressed approaches to more effectively maintain recovery and sustain good function through preventing and resolving barriers to continued care, such as side effects and tailoring of treatment to the needs of the individual patient, and has particularly addressed these needs as relevant to Hispanic Americans. The Division serves as one of 10 centers nationwide in the NIMH Bipolar Trials Network, the purpose of which is to implement innovative clinical studies of treatments that have the potential to substantively improve long term outcomes in bipolar disorders.